{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:22:06Z","timestamp":1793946126492,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0017\/0001"],"award-info":[{"award-number":["RD16\/0017\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0017\/0021"],"award-info":[{"award-number":["RD16\/0017\/0021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["PI16\/01953"],"award-info":[{"award-number":["PI16\/01953"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["PI16\/01698"],"award-info":[{"award-number":["PI16\/01698"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["PI17\/02026"],"award-info":[{"award-number":["PI17\/02026"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["PI19\/00886"],"award-info":[{"award-number":["PI19\/00886"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERDF\/ESF"},{"name":"Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas of Ministerio de Sanidad, Servicios Sociales e Igualdad","award":["PND2017\/017"],"award-info":[{"award-number":["PND2017\/017"]}]},{"name":"Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas of Ministerio de Sanidad, Servicios Sociales e Igualdad","award":["PND2017\/043"],"award-info":[{"award-number":["PND2017\/043"]}]},{"name":"Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas of Ministerio de Sanidad, Servicios Sociales e Igualdad","award":["PND2018\/033"],"award-info":[{"award-number":["PND2018\/033"]}]},{"name":"Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas of Ministerio de Sanidad, Servicios Sociales e Igualdad","award":["PND2018\/044"],"award-info":[{"award-number":["PND2018\/044"]}]},{"DOI":"10.13039\/501100010198","name":"MINECO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERDF\/ESF","award":["SAF2016-78864-R"],"award-info":[{"award-number":["SAF2016-78864-R"]}]},{"name":"Consejer\u00eda de Salud y Bienestar Social, Junta de Andaluc\u00eda","award":["PI-0140-2018"],"award-info":[{"award-number":["PI-0140-2018"]}]},{"DOI":"10.13039\/100009473","name":"Universidad de M\u00e1laga","doi-asserted-by":"publisher","award":["CI-17-415"],"award-info":[{"award-number":["CI-17-415"]}],"id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.pnpbp.2020.109958","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T02:20:02Z","timestamp":1588126802000},"page":"109958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity"],"prefix":"10.1016","volume":"102","author":[{"given":"Rebeca","family":"Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Garc\u00eda-Marchena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Requena-Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Flores-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Araos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodr\u00edguez de Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Colado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2020.109958_bb0005","series-title":"Comorbidity of Substance Use and Mental Disorders in Europe","author":"(EMCDDA), E.M.C.f.D.a.D.A","year":"2016"},{"key":"10.1016\/j.pnpbp.2020.109958_bb0010","series-title":"Global status report on alcohol and health","author":"WHO","year":"2014"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109958_bb0015","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1038\/s41598-019-53312-0","article-title":"Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients","volume":"9","author":"Araos","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109958_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1079\/NRR200133","article-title":"Tryptophan metabolism in alcoholism","volume":"15","author":"Badawy","year":"2002","journal-title":"Nutr. Res. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109958_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/alcalc\/agv085","article-title":"Elevation of kynurenine metabolites in rat liver and serum: a potential additional mechanism of the alcohol aversive and anti-cancer effects of disulfiram?","volume":"51","author":"Badawy","year":"2016","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.pnpbp.2020.109958_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/IJTR.S38189","article-title":"Assessment of the human kynurenine pathway: comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion","volume":"9","author":"Badawy","year":"2016","journal-title":"Int J Tryptophan Res"},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2020.109958_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-979626","article-title":"Decrease in circulating tryptophan availability to the brain after acute ethanol consumption by normal volunteers: implications for alcohol-induced aggressive behaviour and depression","volume":"28","author":"Badawy","year":"1995","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109958_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/alcalc\/agp005","article-title":"Activation of liver tryptophan pyrrolase mediates the decrease in tryptophan availability to the brain after acute alcohol consumption by normal subjects","volume":"44","author":"Badawy","year":"2009","journal-title":"Alcohol Alcohol."},{"issue":"10","key":"10.1016\/j.pnpbp.2020.109958_bb0045","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1176\/ajp.141.10.1212","article-title":"Relationship between changes in plasma amino acids and depression in alcoholic patients","volume":"141","author":"Branchey","year":"1984","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109958_bb0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ajcn\/44.4.453","article-title":"Changes in plasma amino acids during sobriety in alcoholic patients with and without liver disease","volume":"44","author":"Diehl","year":"1986","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109958_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.15288\/jsa.1983.44.215","article-title":"Decrease in plasma amino acids in man after an acute dose of ethanol","volume":"44","author":"Eriksson","year":"1983","journal-title":"J. Stud. Alcohol"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109958_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-3223(88)90109-6","article-title":"Altered conversion of tryptophan to kynurenine in newly abstinent alcoholics","volume":"23","author":"Friedman","year":"1988","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109958_bb0065","first-page":"214","article-title":"Plasma chemokines in patients with alcohol use disorders: association of CCL11 (Eotaxin-1) with psychiatric comorbidity","volume":"7","author":"Garcia-Marchena","year":"2016","journal-title":"Front Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109958_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213791","article-title":"Inflammatory mediators and dual depression: potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders","volume":"14","author":"Garcia-Marchena","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109958_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/pterid-2014-0015","article-title":"Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors","volume":"26","author":"Geisler","year":"2015","journal-title":"Pteridines"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109958_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000135710","article-title":"Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects","volume":"88","author":"Giltay","year":"2008","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pnpbp.2020.109958_bb0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuropharm.2018.04.016","article-title":"Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens","volume":"135","author":"Gimenez-Gomez","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109958_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/alcalc\/agu011","article-title":"Tryptophan metabolism in post-withdrawal alcohol-dependent patients","volume":"49","author":"Gleissenthall","year":"2014","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.pnpbp.2020.109958_bb0095","first-page":"1","article-title":"Tryptophan metabolism and related pathways in psychoneuroimmunology: the impact of nutrition and lifestyle","author":"Gostner","year":"2019","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109958_bb0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/WHE.12.64","article-title":"Serotonin and female psychopathology","volume":"9","author":"Hall","year":"2013","journal-title":"Womens Health (Lond)"},{"issue":"6\u20137","key":"10.1016\/j.pnpbp.2020.109958_bb0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.addbeh.2009.03.010","article-title":"Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base","volume":"34","author":"Hall","year":"2009","journal-title":"Addict. Behav."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109958_bb0110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/ajp.2006.163.4.689","article-title":"Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV","volume":"163","author":"Hasin","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109958_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/nu8010056","article-title":"Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain Axis","volume":"8","author":"Jenkins","year":"2016","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.pnpbp.2020.109958_bb0120","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/nn.3540","article-title":"Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid","volume":"16","author":"Justinova","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2020.109958_bb0125","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.bbi.2010.12.013","article-title":"Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders","volume":"25","author":"Kelley","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109958_bb0130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-3223(94)90630-0","article-title":"Serotonin and alcohol intake, abuse, and dependence: clinical evidence","volume":"36","author":"LeMarquand","year":"1994","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109958_bb0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0006-3223(94)91215-7","article-title":"Serotonin and alcohol intake, abuse, and dependence: findings of animal studies","volume":"36","author":"LeMarquand","year":"1994","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109958_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109958_bb0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","article-title":"Kynurenines: from the perspective of major psychiatric disorders","volume":"279","author":"Myint","year":"2012","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109958_bb0150","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/acer.12651","article-title":"The relationship of alcohol use disorders and depressive symptoms to tryptophan metabolism: cross-sectional data from a Nepalese alcohol treatment sample","volume":"39","author":"Neupane","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2020.109958_bb0155","first-page":"9","article-title":"Determination of l-tryptophan and l-kynurenine in human serum by using LC-MS after derivatization with (R)-DBD-PyNCS","volume":"6","author":"Ohashi","year":"2013","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.pnpbp.2020.109958_bb0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fnmol.2018.00490","article-title":"Oleoylethanolamide, Neuroinflammation, and alcohol abuse","volume":"11","author":"Orio","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109958_bb0165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neuropharm.2014.10.014","article-title":"Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2","volume":"89","author":"Pascual","year":"2015","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109958_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118610","article-title":"Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity","volume":"10","author":"Pedraz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.109958_bb0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fpsyt.2019.00074","article-title":"Sex specific changes in tryptophan breakdown over a 6 week treatment period","volume":"10","author":"Reininghaus","year":"2019","journal-title":"Front Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2020.109958_bb0180","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","article-title":"The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures","volume":"45","author":"Robins","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109958_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109958_bb0190","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/npp.2017.21","article-title":"Attenuating nicotine reinforcement and relapse by enhancing endogenous brain levels of Kynurenic acid in rats and squirrel monkeys","volume":"42","author":"Secci","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109958_bb0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1073\/pnas.51.4.605","article-title":"Plasma amino acid patterns in alcoholism: the effects of ethanol loading","volume":"51","author":"Siegel","year":"1964","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109958_bb0200","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1152\/physrev.00013.2008","article-title":"Alcoholism: a systems approach from molecular physiology to addictive behavior","volume":"89","author":"Spanagel","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pnpbp.2020.109958_bb0205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuropharm.2017.04.013","article-title":"A role for the peripheral immune system in the development of alcohol use disorders?","volume":"122","author":"de Timary","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109958_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2015.17.2\/btolliver","article-title":"Assessment and treatment of mood disorders in the context of substance abuse","volume":"17","author":"Tolliver","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2020.109958_bb0215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1176\/appi.ajp.161.7.1231","article-title":"Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV","volume":"161","author":"Torrens","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"18","key":"10.1016\/j.pnpbp.2020.109958_bb0220","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00213-016-4384-9","article-title":"Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse","volume":"233","author":"Vengeliene","year":"2016","journal-title":"Psychopharmacology"},{"issue":"5603","key":"10.1016\/j.pnpbp.2020.109958_bb0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"issue":"9904","key":"10.1016\/j.pnpbp.2020.109958_bb0230","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584620302748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584620302748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:52:01Z","timestamp":1759521121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584620302748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":46,"alternative-id":["S0278584620302748"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109958","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109958"}}